BioCardia Inc risk profile
66 Stretched several inputs deteriorating together
Measured 21 October 2026 from BCDA's filed statements. Recomputed nightly.
66 (Stretched), driven by Concentration at 85, over 3 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 77 | Stretched | Volatile | One-year price volatility — 65.0% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | 21 | Normal | Stable | Current ratio — 1.12x |
| Competitive position | Reads research_and_development, operating_income, revenue, peer cohort and disclosed transition KPIs. No reading is stored for this company. | |||
| Concentration | 85 | Acute | Stable | Customer concentration — 4,584 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.